Selumetinib
Unknown
Clinically reviewed by MedNext Clinical Team. Last reviewed 1 January 2026. See our editorial policy and correction policy.
Indications
- Inoperable plexiform neurofibromas in patients with neurofibromatosis type 1 (initiated by a specialist) for selumetinib
Safety Information
Cautions
Patients of Asian origin (increased risk of side-effects)
Side Effects
Common or very common Alopecia; anaemia; asthenia; diarrhoea; dry mouth; dyspnoea; fever; hair colour changes; hypertension; hypoalbuminaemia; increas...
Full safety information, contraindications, and dosing available in the MedNext app.
Brand Names
Get the Full Monograph
Complete dosing, interactions, contraindications, side effects, and more for Selumetinib.
Download Free — 7-Day TrialNo credit card required
In the MedNext App
- Complete dosing regimens
- Full interaction details & severity
- AI-powered drug search
- All 1 brand names
- Dosing calculators
- CME/CPD tracking
- 40 language support
- Offline access
Related drugs
Explore other drugs in the same clinical area or patient population.
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare professional before making clinical decisions. Verify all drug information with current clinical guidelines.
Access all 2866 drugs in the MedNext app
Complete monographs, AI-powered search, interaction checker, dosing calculators, and CME tracking — in 40 languages.
Download MedNext — Free 7-Day Trial